Improvements in quality of life associated with biphasic insulin aspart 30 in type 2 diabetes patients in China: results from the A1chieve® observational study

Table 2 HbA _1c , body weight and hypoglycaemia in insulin-naïve and insulin-experienced patients, and in the total cohort

		Insulin-experienced, N = 1,966	Insulin-naïve, N = 6,612	Total cohort, N = 8,578
HbA_1c (%)	N	1056	3386	4442
	Baseline	9.1 (2.3)	9.6 (2.2)	9.5 (2.3)
	Week 24	7.0 (1.1)	7.0 (1.0)	7.0 (1.0)
	Change	-2.0 (2.2)	-2.7 (2.2)	-2.5 (2.2)
	P value	<0.001	<0.001	<0.001
Body weight (kg)	N	1459	4600	6059
	Baseline	68.7 (11.2)	68.5 (11.3)	68.5 (11.3)
	Week 24	69.2 (10.9)	68.8 (10.8)	68.9 (10.8)
	Change	0.5 (3.0)	0.3 (3.1)	0.3 (3.1)
	P value	<0.001	<0.001	<0.001
Overall hypoglycaemia (events/patient year)	N	1966	6612	8578
	Baseline	6.12	1.2	2.32
	Week 24	2.14	1.37	1.54
Nocturnal hypoglycaemia (events/patient year)	N	1966	6612	8578
	Baseline	1.65	0.26	0.58
	Week 24	0.42	0.24	0.28
Major hypoglycaemia (events/patient year)	N	1966	6612	8578
	Baseline	0.37	0.09	0.15
	Week 24	0.00	0.00	0.00
Minor hypoglycaemia (events/patient year)	N	1966	6612	8578
	Baseline	5.75	1.10	2.17
	Week 24	2.14	1.37	1.54

ISSN: 1477-7525